Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Active not recruiting 3Recruiting 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Li-Fraumeni Syndrome 1Hamartoma Syndrome, Multiple 1Breast Carcinoma In Situ 1

Interventions

Fulvestrant 58Trastuzumab 49Capecitabine 48Letrozole 45pembrolizumab 41Carboplatin 41Paclitaxel 39Cyclophosphamide 38ribociclib 37pertuzumab 36abemaciclib 36Blood Specimen Collection 31Specimen Handling 28trastuzumab deruxtecan 27Docetaxel 27Surveys and Questionnaires 26Anastrozole 25exemestane 24Tamoxifen 24palbociclib 21130-nm albumin-bound paclitaxel 21Magnetic Resonance Spectroscopy 20Biopsy 19sacituzumab govitecan 18eribulin 18Radiotherapy 18Gemcitabine 18olaparib 17Injections 17Epirubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Breast Neoplasms × Mastectomy, Subcutaneous × Clear all
NCT06569706 2026-01-05

NEOMAMENDO

University Hospital, Montpellier

Phase NA Recruiting
20 enrolled
Breast

Breast Neoplasms

NCT06676761 2024-11-06

Outcomes of a Novel Technique Minimal Scar Mastectomy

KK Women's and Children's Hospital

Recruiting
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡